Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Sacramento, CA
NPI
1770695181
Since 2006
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
1111 Exposition Blvd, Bldg 700, Ste 102
Sacramento, CA, 95815
Phone (916) 648-9800
Groups this clinician bills Medicare through
Medicare paid, 2024
$2,769
29 services
Medicare patients, 2024
21
Average age 30
Drug cost, 2024
$751K
489 prescriptions
Company payments, 2025
$3,680
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shailesh M Asaikar was code 99215 (office e&m - established), 25 times for 19 patients. In total Shailesh M Asaikar billed 29 services in 3 codes, and Medicare paid $2,769.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 25 | 19 | $97.71 | $2,443 |
By year: 2022 $1,694 for 21 services; 2023 $2,270 for 21 services; 2024 $2,769 for 29 services.
Medicare prescription drug claims, 2024
In 2024, the drug Shailesh M Asaikar prescribed most often to Medicare patients was Epidiolex (Cannabidiol (Cbd)), with 41 prescriptions and refills. In total Shailesh M Asaikar wrote 489 Medicare prescriptions that cost $751K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Epidiolex Cannabidiol (Cbd) | 41 | 46 | Under 11 | $178K |
| Levetiracetam Generic | 26 | 66 | Under 11 | $2,703 |
| Sumatriptan Succinate Generic | 25 | 25 | Under 11 | $2,744 |
| Fintepla Fenfluramine Hcl | 24 | 24 | Under 11 | $473K |
| Phenobarbital Generic | 20 | 36 | Under 11 | $667 |
| Ondansetron Odt Ondansetron | 15 | 15 | Under 11 | $42.76 |
| Olanzapine Generic | 15 | 17 | Under 11 | $282 |
| Topiramate Generic | 14 | 38 | Under 11 | $334 |
| Emgality Syringe Galcanezumab-Gnlm | 14 | 14 | Under 11 | $24K |
| Fluphenazine Hcl Generic | 13 | 13 | Under 11 | $1,300 |
| Fluvoxamine Maleate Generic | 13 | 13 | Under 11 | $390 |
| Quetiapine Fumarate Generic | 13 | 21 | Under 11 | $91.8 |
| Clorazepate Dipotassium Generic | 12 | 12 | Under 11 | $2,625 |
| Fluoxetine Hcl Generic | 12 | 33 | Under 11 | $695 |
| Divalproex Sodium Generic | 12 | 20 | Under 11 | $422 |
Brand drugs: 143 claims; generic drugs: 326 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shailesh M Asaikar $3,680 ($3,680 in general payments such as food, travel and fees) from 18 companies. The largest payer was UCB, Inc. with $674.
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. UCB.BR | 37 | $674 |
| Neurelis, Inc. | 20 | $496 |
| LivaNova USA, Inc. LIVN | 11 | $439 |
| Catalyst Pharmaceuticals, Inc. CPRX | 15 | $413 |
| Tris Pharma Inc | 25 | $293 |
| Aucta Pharmaceuticals, Inc. | 15 | $269 |
| SK Life Science, Inc. | 10 | $257 |
| Supernus Pharmaceuticals, Inc. SUPN | 11 | $199 |
| Jazz Pharmaceuticals Inc. JAZZ | 11 | $194 |
| Biogen, Inc. BIIB | 1 | $112 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.